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ABSTRACT 
Objective: The aim of the present work was to prepare and examine drug release of the oral controlled release microbeads using different curing 
agents by emulsification internal ionic gelation technique. 
Methods: Cross-linked alginate microbeads were prepared with different cross linking agents by using mucoadhesive properties. The formation 
and compatibility of microbeads were confirmed by compatibility studies. Prepared microbeads evaluated for encapsulated efficiency, micromeritic 
properties, drug loading, in vitro wash off studies, in vitro dissolution studies, drug release kinetics and stability studies 
Results: The in vitro drug release was influenced by both type of curing agents and type of polymers and no significant changes in characterization 
parameters was observed after 3 mo stability studies. The sustained release profile of optimized batch was found to be 99.66±0.18% in comparison 
to pure drug profile of 28.64±0.02% at 12 h release study. Results of both wash-off and in vitro studies suggests that batch (SF2) prepared with 
aluminium chloride has shown better mucoadhesive property. Drug release of optimized batch follows zero order with non fickian mechanism 
according to Korsmeyer-Peppas equation.  
Conclusion: The data suggest the use of simvastatin mucoadhesive cross linked microbeads to offer the potential for oral controlled drug delivery 
with improved gastric retention and capable to provide sustained drug release by using cross linking agents. 
Keywords: Simvastatin, Emulsification internal ionic gelation, Gatro-retentive drug delivery system, Mucoadhesive microbeads, In vitro study 
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INTRODUCTION 
Gastroretentive systems can remain in the gastric cavity for several 
hours and prolong the gastric residence time of drugs, maximum 
utilization of drug. The main aim of Gastro-retentive drug delivery 
systems (GRDDS) which prolongs the gastric residence time of the 
formulations by forming strong intimate contact, also improves 
solubility for drugs that are less soluble in a high pH environment 
and prolonged gastric retention improves bioavailability and hence 
therapeutic efficacy, reduced frequency of drug administration, 
reduction in dose size, improved patient compliance and/or to 
achieve a local effect in the stomach [1]. The controlled release 
systems have made significant progress in terms of clinical efficacy 
[2]. Of the several drug delivery systems used, multi-particulate drug 
delivery systems gained significant importance [3]. Simvastatin is 
used in treatment of hyperlipidemic patients and available in 
crystalline state with hygroscopic nature and belongs to BCS class II 
drug with a half-life of less than 3 h and bioavailability of less than 
5% as its limited by absorption rate factor [4]. It often shows 
dissolution rate-limited oral absorption. Controlled release 
formulation (CR) describes sustained action along with its 
reproducibility and predictability of release of active drug 
ingredients from the drug delivery system [5]. Therefore, 
progressive results in both solubility and dissolution rate may lead 
to enhancement in bioavailability of drug. Oral controlled release 
particulate systems like microbeads, pellets, microspheres and 
micro particles etc. are becoming more effective than the single unit 
dosage forms, as these systems tend to distribute more uniformly 
over the entire region of gastro intestinal tract and high local drug 
concentration as well as risk of toxicity can be avoided. Multi-
particulate systems also avoid the vagaries of gastric emptying and 
different transit rates; thereby release the drugs more uniformly [6]. 
Sodium alginate has been commonly used in the designing of 
GRDDS. Sodium alginate can be used as a major polymer because of 
its unique characters as biodegradable, bio-compatibility, non-toxic 
and in addition it has gained mucoadhesive properties also [7]. 
Hydroxypropyl methylcellulose (HPMC K4M) is a nonionizable 
water soluble polymer contains large number of hydroxyl groups 
which favors adhesion [8] and with its high molecular weight results 
in more viscous gel [9] and to provide drug release in slow manner. 
These polymers form a viscous gel layer once when they reach the 
contents of gastric fluids. Alginate easily forms cross-linking with 
polyvalent cations which result in the formation of stable gel-like 
matrices. In combination of above polymers it is possible to attain 
mucoadhesive drug delivery system [10]. These hydrophilic 
polymers were used in this work were to produce adhesion during 
hydration [11]. The Mucoadhesive dosage forms may facilitate to 
provide prolonged retention time at the application site, drug 
release occurs in a controlled rate for enhanced improvement of 
therapeutic activity [12]. Since this combination of hydrophilic 
polymers having characteristics in swelling/erosion concept [13], 
which can produce drug release in controlled release pattern.  
MATERIALS AND METHODS 
Materials 
The pure drug simvastatin was obtained as a gift sample from 
Aurobindo pharma limited, Hyderabad, Telangana state, India. 
Hydroxypropylmethylcellulose K4M, Sodium alginate was 
purchased from Himedia, Mumbai, Sodium carboxymethyl cellulose 
1100-1900cps, Carbopol 934, calcium chloride (CaCl2.2H2O), Barium 
chloride (BaCl2.2H2O), Aluminium chloride, N-Hexane, light liquid 
paraffin, Chloroformr, Hydrochloric acid, Potassium dihydogen 
phosphate, Ethyl vinyl acetate (EVA) and Methanol solution were 
obtained from Qualigens fine chemicals, Mumbai. All chemical 
agents used were of analytical high grade quality. 
Equipments 
Digital electronic weighing balance (0.1 mg sensitive, Shimadzu, 
Mumbai), Sigma blade homogenizer (Remi model, India), Desiccator 
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(Borosilicate, Mumbai), Sonicator (Remi model, Mumbai,India), 
Dissolution test apparatus USP (Model TDT-08L, Electro-lab, Mumbai, 
India), Tablet disintegrating test apparatus (USP model, India), Double 
beam UV-Visible spectrophotometer, (Elico SL-210), Fourier-
transform infrared spectrophotometer (FTIR, Bruker, X-ray 
diffractometer (Model PW/1710, Poland), Differential scanning 
calorimetry (Netzsch, Japan) Scanning electron microscope (S-3700 N 
SEM, Hitachi) and Syringe and Needle 23 G, etc. 
 
Table 1: Formulation of simvastatin microbeads with various curing agents 
Batch code Polymers used Percentage of polymers (% w/v) Curing agent (5% w/v) 
SF1 Sodium alginate 3 Alcl+3 
SF2 Sodium alginate+Hydroxy Propyl Methyl Cellulose K4M 1.5:1:5 Alcl+3 
SF3 Sodium alginate+Carbopol 934P 1.5:1:5 Alcl+3 
SF4 Sodium alginate+Sodium CMC 1100-1900cps 1.5:1:5 Alcl+3 
SF5 Sodium alginate+Hydroxy Propyl Methyl Cellulose K4M 1.5:1:5 Bacl+2 
SF6 Sodium alginate+Hydroxy Propyl Methyl Cellulose K4M 1.5:1:5 Cacl+2 
*All batches containing core and coat ratio is 1:3. 
 
Methods 
Preparation of simvastatin loaded microbeads 
The simvastatin loaded cross-linked alginate microbeads were 
prepared by choosing emulsification internal gelation method. 
Simvastatin equivalent to 20 mg was dissolved in sufficient amount of 
methanol on a magnetic stirrer by stirring at 250 rpm at room 
temperature only. Simvastatin solution was incorporated in a beaker 
containing mixture of sodium alginate and different types of 
hydrophilic polymers with different concentrations (listed in table 1) 
with continuous stirring using homogenizer at a speed of 400 rpm to 
obtain homogenous viscous solution. This solution is kept inside 
sonicator for 2 h in order to remove air bubbles completely. Take the 
above solution in a beaker and add 30 ml of selected cross-linking 
agent at 5% w/v drop wise in a beaker which is stirred undisputedly 
with sigma blade homogenizer at 600 rpm and keep on mixing for 30 
min. The above physical mixture solution take into 10 ml syringe 
which is fitted with 22 gauze needle and pressed gauze then discharge 
solution drop wise into 250 ml glass beaker containing mixture of 100 
ml light liquid paraffin oil and concentration of span 80 (1.5 % w/v) 
and glacial acetic acid at 0.2 % w/v. During the addition of syringe 
solution, it was sure to keep the minimum 10 cm distance between tip 
of needle and beaker. The above viscous solution was stirred at a 
speed of 600 rpm by using sigma blade homogenizer continuously for 
a period of 30 min and this solution in later filtered through filter 
paper, it will form high viscous product with insoluble residue and in 
order to remove stickiness of viscous product, it was washed 
continuously four to six times with concentrated n-Hexane solution 
until sticky fatty material has entirely removed and place wet 
microbeads in desiccator overnight until it becomes completely dried 
and collect dried cross linked microbeads.  
Characterization of simvastatin microbeads 
Determination of maximum wavelength for pure simvastatin 
Weigh pure simvastatin 10 mg exactly and transferred to 10 ml 
standard volumetric flask. Add few drops of ethanol until all 
simvastatin solubilized completely. Withdraw the 1 ml of above 
solution and made up to final volume 10 ml with distilled water to 
get final concentration of 10 μg/ml. The absorbance of the final 
solution was scanned in the UV wave length of 400-200 nm against 
distilled water as a blank solution 
Micromeritic properties of the microbeads 
The prepared cross linked microbeads were characterized for angle of 
repose, tapped density, bulk density, carrs index and Hausner’s ratio 
[14]. 
Percentage of yield 
Percent yield defined as the percent ratio of practical yield (obtained 
dried microbeads) to the theoretical yield (weight of used polymers and 
drug weight). Mathematically it is computed from following equation. 
 
Size Distribution and size analysis 
The size of microbeads will be determined by sieving method. The 
amount of uniformed microbeads which were retained on different 
individual sieves were taken out and weighed accurately. Finally the 
mean particle size of the microbeads was determined by using 
following equation. 
 
Entrapment efficiency of microbeads 
Entrapment efficiency was resolved quantitatively by using the following 
formula. For calculation of drug content, 20 mg of beads were placed in a 
cleaned dry mortar and crushed to fine powder. Limited amount of 
methanol was added to the grinded powder to dissolve simvastatin 
completely and later sonicated for 30 min in order to get clear solution. 
The above solution was filtered through a membrane filter (0.45 µ). The 
clear filtered solution was diluted with little amount of methanol and 
subsequently with distilled water and drug concentration was measured 




Few microbeads samples were selected randomly and powdered to 
fine state by grinding in mortar. Weigh the above powder which is 
equivalent to 100 mg was transferred into 100 ml standard 
volumetric flask containing few drops of ethanol and shake it 
vigorously until completely solubilized and made to the final volume 
by distilled water only. The flask was placed in a sonicator till 
powder is completely solubilized. The above solution was filtered by 
using filter paper (0.45 μm pore size) and from this 1 ml was taken 
and transferred to 100 ml volumetric flask which was made up to 
the mark by distilled water. The absorbance of the solution was 
measured using double beam UV/Vis spectrophotometer against the 
distilled water as a blank at 233 nm for estimation of simvastatin. 
Fourier-transform infrared (FTIR) spectroscopy analysis 
The IR spectra of pure simvastatin and physical mixture containing 
simvastatin and excipients were obtained using FTIR 
spectrophotometer. The above samples weighed approximately 1 to 
2 mg were blended with potassium bromide and compressed highly 
with maximum pressure to form disks and these disks were scanned 
from 4000 to 400 cm-1. 
Differential scanning calorimetry (DSC) studies 
DSC evaluation was performed to find out the physical state of the 
simvastatin in microbeads using a DSC instrument and it helpful to 
study their thermal behavior of samples. For analysis, nearly 4 mg of 
sample was taken within a sealed aluminium crucible and it placed 
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into a temperature controlled DSC cell and the temperature range 
was measured from 30 to 400 ° C and samples were scanned at 
speed of 20 °/min. 
X-Ray diffraction studies (XRD studies) 
X-ray diffraction patterns were recorded using Cu Kα radiation, 
usually operated at 40 kV voltage and 40 mA current. The microbeads 
samples were recorded 0.025° step resolution, in the 2θ ranges from 
10° to 60° for the simvastatin, blank and loaded microbeads. 
Scanning electron microscopic (SEM) studies 
The purpose of this study is to confirm the morphology 
characteristics i.e. shape, size and surface (texture) of dosage form. 
Tests were sputter-covered with gold under a vacuum before 
perception with a scanning electron microscope at an increasing 
speed voltage of 10 kV.  
In vitro wash off test 
The mucoadhesive property of prepared microbeads will be 
determined by conducting in vitro wash off studies. The 
mucoadhesiveness of prepared microbeads will be compared with 
ethyl vinyl acetate microbeads (Non mucoadhesive material). A 
fresh piece of intestinal mucosa approximately 2x2 cm was obtained 
from goat and fix onto a glass slides (3x1 inch) with cyanoacrylate 
glue. These two glass slides were connected with a suitable support 
which is connected to a shaft which is facilitated with up and down 
movement with electric motor (Modification of disintegration test 
apparatus, USP). About 100 microbeads were spread uniformly onto 
each wet rinsed mucosa specimen and without delay the support 
was hung on to a arm of tablet disintegration test apparatus. When 
the machine is plugged on, slide was given series of up and 
downward movement continuously in a beaker which contains 900 
ml test fluids. The whole assembly was maintained a temperature of 
37 °C though out the procedure. The test was performed first in 0.1N 
HCl for 2 h and later in 6.8 phosphate buffer solution. At the end of 
1,2,4,6, 8 and 10 h the machines were stopped for a while and count 
the number of microbeads still adhering/sticking on to mucosa was 
counted and run the machine until end of the last period. 
Dissolution test 
In vitro drug release of the samples was carried out in accordance to 
the USP dissolution method (Type II dissolution apparatus, basket 
type, Electrolab TDT-08L). The dissolution mediums (900 ml of 0.1N 
HCl for first 2 h and 900 ml of 6.8 phosphate buffer from 3rd h 
onwards to 12 h) was placed alternatively in the dissolution basket 
and maintain a temperature of 37±0.5 ° C and agitation was started 
at 100 rpm. To the above buffer medium add 1 % Tween 20. One 
milliliter of sample was withdrawn periodically at every 1 h 
intervals of time up to 12 h. After every withdrawal of sample, the 
dissolution medium was replaced with the same quantity of fresh 
buffer each time throughout the procedure to maintain sink 
conditions. Withdrawn samples were filtered through filter paper 
(0.45 μm pore size) and after series of appropriate dilutions the 
samples were analyzed for the concentration of simvastatin using 
double beam UV/Vis spectrometer at 233 nm [15]. The cumulative 
percentage drug release was calculated. Each absorbance reading 
was taken in triplicate manner (n=3). 
Release kinetics 
In vitro drug release data was subjected to different kinetic models 
like zero order, first order, Higuchi matrix, Korsmeyer-Peppas in 
order to investigate the release pattern of all formulated batches. 
For each kinetic model, correlation coefficient (R2) was calculated. 
To characterize the drug release rate (kinetics) in different 
experimental conditions, both T50% and T80% were calculated from 
dissolution data according to the following equations. 
T50% = (0.5/k)1/n 
T80% = (0.8/k)1/n 
Stability studies 
Accelerated stabilities studies for the optimized batch were stored in 
stability chamber under different conditions of 25°±2°/60±5 % RH 
and 40±20 °C/75±5 % RH. The samples were examined for drug 
content after the time intervals of 90 d. The drug content, entrapment 
efficiency, in the samples was analyzed spectrophotometrically. 
RESULTS AND DISCUSSION  
Determination of λmax for pure simvastatin  
After scanning of simvastatin solution containing concentration of 
10 μg/ml using double beam spectrophotometer in the range of 200 
to 400, the maximum absorbance was taken place at 233 nm. Each 
reading taken in triplicate manner i.e. n=3. 
 
 
Fig. 1: UV Spectrum of pure simvastatin 
 
The λ max of pure simvastatin was found to be 233 nm by scanning 
the diluted sample whose concentration ranging from 2-20 μg/ml by 
using double beam UV-Visible spectrophotometer. The obtained UV 
λmax spectrum was shown in the fig. 1. 
Micromeritic properties of microbeads 
The rheological parameters like angle of repose, tapped density, 
bulk density and packing properties (table 2) confirms that 
microbeads having fair flow properties. All the batches showed 
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angle of repose value within the accepted range of 21.16° to 23.66° 
which is the considerable range for microbeads to show good flow 
property while formulating in the desired dosage form. Each reading 
was taken in triplicate manner. 
 
Table 2: Flow properties of various batches containing simvastatin microbeads 
Batch code Angle of repose (θ) Bulk density (g/cm3) Tapped density (g/cm3) Carr’s index (%) Hausner’s ratio 
SF1 21.92±0.93 0.704±0.77 0.824±0.15 14.56±0.04 1.17±0.18 
SF2 21.16±0.01 0.941±0.02 1.072±0.02 12.82±0.02 1.14±0.05 
SF3 22.17±0.04 0.812±0.03 0.926±0.05 12.81±0.04 1.14±0.02 
SF4 22.89±0.05 0.897±0.03 1.058±0.07 13.13±0.06 1.16±0.03 
SF5 22.45±0.03 0.799±0.05 0.958±0.04 14.36±0.05 1.20±0.02 
SF6 23.66±0.05 0.928±0.08 1.076±0.06 12.71±0.04 1.16±0.03 
 *All values are expressed as mean±SD (n=3). 
 
The microbeads prepared with aluminium chloride as a curing agent 
will form small particle size in comparison to microbeads prepared 
with divalency curing agents naming calcium chloride and barium 
chloride. The main reason for above statement is change in 
development of cross linking network inside lattice of alginate beads 
during cross linking time. The order of magnitude of cross linking 
network is more in aluminium chloride (Trivalency ions) than 
remaining curing agents (Divalency ions). The presence of extra 
charge in Al+3 owns large cross linking network during curing time. 
The small shrinkage of microbeads occurs only when using Alcl+3 as 
a curing agent. 
Entrapment efficiency and drug loading 
The entrap efficiency of simvastatin was found to be directly 
proportional to the concentration of the sodium alginate, low 
concentration of physical mixture will give lower viscosities which 
leads to lower encapsulation of drug. Of all three curing agents, 
AlCl+3 which is used as curing agent from batch SF1 to SF4 will only 
show maximum entrapment efficiency o because tight compact of 
microbeads that has been formulated with Al+3 and not get leakage 
from surface of wet microbeads during curing time and process of 
homogenization, in contrast microbeads prepared with BaCl+2 and 
Cacl+2 (SF5 and SF6 batches) as curing agents soft walled cross 
linked microbeads will formed and it shows less entrapment 
efficiency. The reason for less entrapment efficiencies is due to easy 
leakage of drug from the soft surface of microbeads during curing 
time and homogenization. The entrapment efficiency of the various 
formulations was found in between 90.28±0.03 to 97.16±0.02 % and 
details were shown in table 3. Of all batches, SF1 batch shows less 
percentage of efficiency as it contains only single polymer, in 
contrast to this, more entrapment was observed when microbeads 
prepared with blend of polymers (SF2 to SF6 batches). The presence 
of more functional groups present in combination of polymers 
guarantees the more entrapment of drug during the cross 
processing linking time.  
The less entrapment was observed in SF5 and SF6 batch relatively to 
microbeads prepared with trivalency curing agent (SF2 to SF4 
batches). The difference in percent of entrapment efficiency occurs 
due to leakage of drug during curing time and homogenization 
period from the surface of wet microbeads and this is particularly 
observed when microbeads designed with divalency cross linking 
agent.
 
Table 3: Evaluation of simvastatin microbeads 




Drug content Entrapment 
Efficiency* (%) 
SF1 98.65 173.42±0.06 24.29±0.03 85.16±0.02 
SF2 97.45 167.25±0.05 23.44±0.05 93.68±0.03 
SF3 98.36 181.33±0.06 23.68±0.03 94.72±0.04 
SF4 97.16 180.41±0.03 24.13±0.04 96.52±0.03 
SF5 96.36 181.32±0.04  23.41±0.03 91.64±0.02 
SF6 96.23 176.37±0.02 23.32±0.03 90.28±0.03 
 *All values are expressed as mean±SD (n=3). 
 
 
Fig. 2: FTIR image showing pure simvastatin (Above spectra) and simvastatin loaded microbeads (Below spectra) 
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Infrared spectroscopy 
Fig. 2 shows IR spectrum of Pure simvastatin drug and drug with all 
excipients which used in formulation having characteristic 
absorption band in the following regions. 3392.78 cm-1(alcoholic O-
H stretching vibration), 2933.68 cm-1(methyl and methylene C-H 
asymmetric and symmetric vibration, C=O stretching 1961.67 cm-1, 
1701.27 cm-1 (lactone C=O and ester C=O stretching), 1267.27 cm-1 
(methyl and methylene C-H bending vibration) and 1065.10 cm-
1(ester C-O-C bending vibration) respectively. 
FTIR spectrum of co-grinding mixture showed peak values at 
3373.81, 2923.48, 1923.45, 1695.06, 1264.23 and 1012.00 cm-1 
which showed that the intensities of these peaks were reduced in 
the co-grinding mixture and slight shift in the peak values indicates, 
the excipients and simvastatin were mixed without any chemical 
interactions. The reduced in intensities and number of peaks gives 
clear indication of reducing the crystalline nature and making the 
drug amorphous which helpful in better absorption. The obtained 
FTIR spectras was shown in fig. 2. 
DSC studies 
DSC thermogram of pure drug simvastatin showed sharp endotherm 
peak at 136.47 ° C corresponds to its melting point. There was no 
appreciable change in the melting endotherms 136.52 ° C for 
optimized formulation compared to that of pure simvastatin. This 
thermographic results show that the drugs retain its identity in the 
optimized formulation. This observation also confirmed the absence 
of chemical interaction of drug with additives during process, 
further it also supports the results of IR spectroscopy. The obtained 
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Fig. 3: DSC spectra of pure simvastatin (Above spectra), pure sodium alginate (Middle spectra) optimized batch (bottom spectra) 
 
Powder X-ray diffraction (PXRD) studies 
The diffraction pattern of the pure drug simvastatin shows a highly 
crystalline nature, indicated by numerous distinctive peaks at a 
diffraction angle of 2θ (28.4°, 24.6° and 15.2° throughout the 
scanning range. The results of the PXRD pattern of pure drug and 
optimized formulation are shown in fig 4. Pure drug and the 
optimized formulation showed the almost same peaks but with 
reduced intensity in height of peaks and in much diffused pattern 
were observed in optimized batch (SF2) which gives clear indication 
of conversion of crystalline state to the amorphous nature of drug. 
This decrease in crystallinity of drug present in surface of alginate 
beads which resulted in an increased dissolution rate of simvastatin 
and also it confirms the absence of chemical interaction of drug with 
the optimized formulation and well dispersion of drug in polymeric 
matrix beads. 
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Fig. 4: XRD spectra of pure simvastatin and optimized formulation of simvastatin 
 
 
Fig. 5: SEM photograph of microbead 
 
Table 4: In vitro wash-off test values for the simvastatin microbeads prepared with combination of sodium alginate and HPMC K4M in 1:3 
ratios by employing various cross linking agents at 5 %w/v 
Batch Percent of alginate beads adhering to tissue at 6 times (h) 
0.1 N HCl, pH 1.2* Phosphate Buffer, pH 6.8* 
1 2 4 6 8 10 1 2 4 6 8 10 
SF2 65±1.3 53±1.5 44±1.3 36±1.6 27±1.7 26±1.4 92±0.4 85±1.2 76±1.4 63±1.3 54±1.4 20±1.4 
SF5 62±1.0 51±1.5 39±1.3 30±1.4 19±1.2 18±1.9 89±0.8 83±1.2 73±1.4 61±1.6 50±1.3 16±1.3 
SF6 60±1.4 49±1.2 37±1.5 22±1.6 14±1.4 13±1.6 86±0.4 78±1.2 69±1.4 57±1.3 44±1.8 14±1.8 
EVA 
microbeads 
50±1.3 38±1.2 08±1.6 - - - 47±2.1 36±1.9 05±2.0 - - - 
*All values are expressed as mean±SD (n=3).  
 
Scanning electron microscopic study 
SEM study revealed that the cross linked microbeads were nearly 
spherical in shape and arranged in discrete manner and shape of 
microbead was shown in fig. 5. 
In vitro wash-off studies 
The wash off was faster at simulated intestinal pH (phosphate buffer 
6.8) than comparison to that at simulated gastric pH (1.2) [16]. The 
rapid wash-off observed intestinal pH than at gastric pH, the reason 
may be contributed is due to the ionization of carboxyl acid groups 
[17] and other functional groups present along the polymers chain at 
alkaline atmosphere, which increases the solubility and reduce the 
mucoadhesive strength. The results of wash off test (table 4) suggest 
that mucoadhesive microbeads had fairly mucoadhesive properties. 
In vitro dissolution studies 
Hydrophilic nature of HPMC K4M facilitates penetration of 
dissolution medium into the network structure of alginate polymer 
chain thereby leads to hydration of the polymer blend hence 
swelling of microbeads takes place during dissolution process. The 
drug release profile of different is shown in fig. 5. The formulated 
microbeads showed increase drug release profile in 6.8 phosphate 
buffer medium than 0.1N HCl medium comparatively. The main 
reason behind the increase in drug release is based on two 
principles, primary one is relaxation of polymers due to difference in 
osmotic pressure/increase stress of beads thereby it renders to 
increase in surface area of wet microbeads which leads to create 
micron size pores on surface of enlarged beads (swelled beads) and 
second principle is that disintegration of cross-linked alginates 
microbeads occurs through ion exchange between bound 
Ca+2/Ba+2/Al+3 ions and sodium ions present in phosphate buffer 
medium. Formation of gelatinous layer during dissolution process 
acts as a boundary layer for drug that has to be released. At one 
stage after complete hydration of microbeads as the polymer chains 
becomes beyond levels of hydration, erosion takes place [18]. The 
increase or decrease of drug release depends upon nature of 
dissolution medium and the type of cross linking agent used. In this 
work two divalency and one trivalency curing agents were used for 
promoting cross-linking network (between carboxylate residues of 
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G and M-blocks of sodium alginate and curing agent) during curing 
time. Sodium alginate could form gel in the presence of different 
multivalent cations such as Al+3, Ca+2 and Ba+2 by ionic cross-linking 
[19] to form microspheres/microbeads. Of entire study, decreased 
swelling rate was observed when microbeads prepared with 
aluminium chloride than calcium chloride and barium chloride as a 
curing/hardening agent. The intensity of cross-linking network was 
very compact with aluminium chloride in comparison to remaining 
two divalency curing agents. The extent of drug release depends 
upon swelling of microbeads in different dissolution mediums. 
Because of one extra valency electron present in aluminium chloride 
(Al+3) as it favors extreme cross-linking network than with divalency 
curing agents (Ba+2 and Ca+2) during gelation process. Therefore 
microbeads prepared with aluminium chloride as a curing agent 
showed better retarded effect when compared to other two curing 
agents (barium chloride and calcium chloride) over a period of 12 h 
 
 
Fig. 5: Comparative dissolution profile of batches from SF1 to SF6. All values are expressed as mean±SD (n=3) 
 
A previous study indicated that alginate beads gelled in Ba+2 
solutions were larger than those gelled in Ca+2 solution [20, 21]. 
The microbeads cross linked with Ca+2 (SF6 batch) shrank fastly 
than remaining curing agents [22]. Based upon pattern of drug 
release it was clearly understood that drug release is pH 
dependent. The relaxation of polymer chains takes place in 
alkaline medium. The drug release mechanism from the 
microbeads was supercase 2ndtransport [23] as n value is more 
than unity. The optimized batch SF2 was shown its sustained 
release up to 12 h by releasing the 99.66% of drug in comparison 
to pure simvastatin sample which released 28.64% in same time 
under standard specific conditions. 
 
 
Fig. 6: Comparative dissolution profile of optimized batch and pure simvastatin. All values are expressed as mean±SD (n=3) 
 
The release kinetics both T50% and T80% were calculated from 
dissolution data and is shown in table 5. The delaying of drug release 
was facilitated by using blend of polymers (SF2 to SF6 batches) and 
type of cross linking agents. The hindrance in drug release is 
possible when microbeads undergoing maximum cross linking 
network, thereby microbeads will develop densed walls and it was 
proved by using trivalency curing agent only. The controlled release 
phase may be attributed to the swelling or erosion of the polymer 
chains, which leads to the creation of small pores within the 
polymeric matrix [24]. 
Stability studies 
The developed Simvastatin microbeads were observed for drug 
content, Percent encapsulation efficiency, Drug loading and 
dissolution kinetics after keeping the product in specified standard 
conditions of stability studies (table 6). Furthermore all 
characterization parameters of optimized batch remained 
unchanged at different storage conditions during the entire period 
of stability studies. It was shown that no change was observed with 
test results at the end of three months indicating that simvastatin 
remained chemically stable in cross-linked microbeads. 
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Table 5: In vitro dissolution kinetics parameters Simvastatin microbeads prepared with sodium alginate and polymer blend in equal 
ratios (1.5:1.5) by employing with various cross linking agents 













SF1 0.9997 0.8446 0.9185 0.9994 4.9 4.08 7.34 1.0673 
SF2 0.9997 0.7791 0.9176 0.9986 3.34 5.99 10.77 1.0797 
SF3 0.9997 0.7916 0.9214 0.9942 3.6 5.55 10.00 1.1035 
SF4 0.9996 0.8006 0.9260 0.9983 3.97 5.03 9.06 1.0269 
SF5 0.9986 0.7482 0.9329 0.9990 3.57 5.6 10.08 1.0412 
SF6 0.9992 0.7572 0.9261 0.9985 3.92 5.1 9.18 1.0219 
*All values are expressed as mean±SD (n=3). 
 
Table 6: Drug content, encapsulation efficiency and dissolution kinetics of optimized simvastatin microbeads (SF2) stored at 25±2 














1st month 23.44±0.05 93.68±0.03 3.34 5.99 10.77 
2nd month 23.44±0.05 93.68±0.03 3.34 5.99 10.77 




1st month 23.44±0.05 93.68±0.03 3.34 5.99 10.77 
2nd month 23.44±0.05 93.68±0.03 3.34 5.99 10.77 
3rd month 23.44±0.05 93.68±0.03 3.34 5.99 10.77 
*All values are expressed as mean±SD (n=3). 
 
CONCLUSION 
The drug release of optimized batch (SF2) containing sodium alginate 
and hydroxyl propyl methyl cellulose K4M that cross-linked with 5% 
w/v aluminium chloride has sustained drug release up to 12 h. The 
extent of drug release rate, and mechanisms were found to be 
governed by the two parameters naming blend of polymers and type 
of curing agents used. Micro beads obtained were having spherical 
shape. The drug release mechanism was found to be super case II 
transport; dependent on both drug diffusion and relaxation of polymer 
chains. The results of In vitro wash-off test has proved optimized batch 
has better mucoadhesive property. Thus simvastatin microbeads 
retained for longer time in gastro intestinal region which leads to 
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